Answers are grounded in this paper and cite their sources.
This review will summarize the role of integrase in HIV-1 infection, the mechanism of integrase inhibitors and resistance with an emphasis on raltegravir (RAL), the first integrase inhibitor licensed to treat HIV-1 infection
No takes yet. Share an insight, caveat, or question.
Daria J. Hazuda (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: